7 months ago
1
The Madras High Court has rejected a Letters Rogatory (a petition for planetary judicial assistance) issued by the territory tribunal of Delaware successful the United States for securing oral and documentary grounds from a Chengalpattu based pharmaceutical institution successful transportation with a patent quality betwixt Pfizer and Cipla.
A Division Bench of Justices G. Jayachandran and Mummineni Sudheer Kumar held that the Letters Rogatory isued by the US tribunal connected May 13, 2024 could not beryllium honoured since Article 23 of the Hague Convention permits signatory countries to garbage requests that were successful the quality of pre-trial find of evidence.
The judges pointed retired that Pfizer, a fashionable American pharma company, had instituted a civilian suit earlier the territory tribunal of Delaware against Indian pharma majors Cipla and Zenara for alleged infringement of its patent with respect to the cause Vyndamax utilized for treating transthyretin amyloid cardiomyopathy.
Cipla and Zenara had entered into a declaration with Softgel Healthcare Private Limited, located astatine Kelambakkam-Vandalur Road successful Pudupakkam village, for manufacturing their cause and hence, Pfizer had obtained the Letters Rogatory from the Delaware tribunal to grounds the grounds of the Chengalpattu based pharma company.
Pfizer urged Madras High Court to honour the Letters Rogatory by appointing a Legal Commissioner, knowledgeable some successful chemistry arsenic good arsenic the ineligible procedures, for postulation of the grounds successful the beingness of a ‘Confidentialiy Club’ comprising Indian and American advocates representing some the parties.
A azygous justice of the High Court had, successful January this year, acceeded to Pfizer’s petition and appointed a Legal Commissioner for postulation of some oral and documentary evidence. He had besides constituted the Confidentiality Club and therefore, Softgel had taken his bid connected entreaty earlier a Division Bench.
Senior counsel V. Raghavachari, representing the appellant, contended that his lawsuit could not beryllium forced to disclose confidential accusation since it would beryllium prejudicial to its interests. He besides said, Pfizer could not beryllium allowed to behaviour a roving enquiry nether the guise of the Letters Rogatory.
Finding unit successful his submissions, the Bench led by Justice Jayachandran took enactment that Pfizer’s exertion seeking patent for the cause successful India had been rejected and an entreaty against specified rejection was inactive pending. Therefore, the quality of the litigation successful the US and the patent entreaty successful India were inter-linked, it said.
“In specified circumstances, this appellant (Softgel), who is neither a enactment earlier the United States territory tribunal nor connected with immoderate commercialized of respondents (Pfizer), cannot beryllium forced to portion distant with documents erstwhile determination is simply a imaginable menace to the appellant’s registered Indian patent,” the Division Bench wrote.
Further, holding that the Letters Rogatory was vague and does not incorporate circumstantial deails arsenic mandated nether Article 3 of the Hague Convention, ratified by some India and the United States, the judges said, the appellant excessively was entitled to workout its close nether Article 11 of the Convention and garbage to springiness evidence.
“The privilege to garbage besides arises from Article 23 work with the notification of the Government of India which excludes execution of a Letters Rogatory successful respect of pre-trial find of documents,” the Division Bench said and acceptable speech the orders passed by the azygous justice successful favour of Pfizer.
